References
- Jiang DM, Gupta S, Kitchlu A, Meraz-Munoz A, North SA, Alimohamed NS, Blais N, Sridhar SS. Defining cisplatin eligibility in patients with muscle-invasive bladder cancer. Nat Rev Urol. 2021;18(2):104–14.
- Hamano H, Ikeda Y, Goda M, Fukushima K, Kishi S, Chuma M, Yamashita M, Niimura T, Takechi K, Imanishi M, Zamami Y, Horinouchi Y, Izawa-Ishizawa Y, Miyamoto L, Ishizawa K, Fujino H, Tamaki T, Aihara KI, Tsuchiya K. Diphenhydramine may be a preventive medicine against cisplatin-induced kidney toxicity. Kidney Int. 2021;99(4):885–99.
- Assi S, Barling M, Al-Hamid A, Cheema E. Exploring the adverse effects of chemotherapeutic agents used in the treatment of cervical and ovarian cancer from the patients' perspective: a content analysis of the online discussion forums. Eur J Hosp Pharm. 2021;28(Suppl 2):e35–e40.
- Abadi AJ, Mirzaei S, Mahabady MK, Hashemi F, Zabolian A, Hashemi F, Raee P, Aghamiri S, Ashrafizadeh M, Aref AR, Hamblin MR, Hushmandi K, Zarrabi A, Sethi G. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. Phytother Res. 2021. doi: 10.1002/ptr.7305.
- Rottenberg S, Disler C, Perego P. The rediscovery of platinum-based cancer therapy. Nat Rev Cancer. 2021; 21(1):37–50.
- Luo Y, Fu Y, Huang Z, Li M. Transition metals and metal complexes in autophagy and diseases. J Cell Physiol. 2021;236(10):7144–58.
- Gill MR, Vallis KA. Transition metal compounds as cancer radiosensitizers. Chem Soc Rev. 2019; 21;48(2):540–57.
- Golbaghi G, Castonguay A. Rationally Designed Ruthenium Complexes for Breast Cancer Therapy. Molecules. 2020;25(2):265.
- Hussain A, AlAjmi MF, Rehman MT, Amir S, Husain FM, Alsalme A, Siddiqui MA, AlKhedhairy AA, Khan RA. Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies. Sci Rep. 2019;9(1):5237.
- Zhang JX, Pan M, Su CY. Synthesis, photophysical properties and in vitro evaluation of a chlorambucil conjugated ruthenium(ii) complex for combined chemophotodynamic therapy against HeLa cells. J Mater Chem B. 2017;5(24):4623–32.
- Čanović P, Simović AR, Radisavljević S, Bratsos I, Demitri N, Mitrović M, Zelen I, Bugarčić ŽD. Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity. J Biol Inorg Chem. 2017;22(7):1007–28.
- Petrovic M, Popovic S, Baskic D, Todorovic M, Djurdjevic P, Ristic-Fira A, Keta O, Petkovic V, Koricanac L, Stojkovic D, Jevtic V, Trifunovic S, Todorovic D. The Effects of Newly Synthesized Platinum(IV) Complexes on Cytotoxicity and Radiosensitization of Human Tumour Cells In Vitro. Anticancer Res. 2020;40(9):5001–13.
- Liu G, Pei F, Yang F, Li L, Amin AD, Liu S, Buchan JR, Cho WC. Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer. Int J Mol Sci. 2017;18(2):367.
- Soofiyani SR, Hejazi MS, Baradaran B. The role of CIP2A in cancer: A review and update. Biomed Pharmacother. 2017;96:626–33.
- Kashyap D, Garg VK, Goel N. Intrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis. Adv Protein Chem Struct Biol. 2021;125:73–120.
- Kędzierska H, Piekiełko-Witkowska A. Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer. Cancer Lett. 2017;396:53–65.
- Amidfar M, Karami Z, Kheirabadi GR, Afshar H, Esmaeili A. Expression of Bcl-2 and Bax genes in peripheral blood lymphocytes of depressed and nondepressed individuals. J Res Med Sci. 2019;24:41.
- Bjelogrlić SK, Todorović TR, Kojić M, Senćanski M, Nikolić M, Višnjevac A, Araškov J, Miljković M, Muller CD, Filipović NR. Pd(II) complexes with N-heteroaromatic hydrazone ligands: Anticancer activity, in silico and experimental target identification. J Inorg Biochem. 2019; 199:110758.
- Zafar MN, Butt AM, Chaudhry GE, Perveen F, Nazar MF, Masood S, Dalebrook AF, Mughal EU, Sumrra SH, Sung YY, Muhammad TST, Wright LJ. Pd(II) complexes with chelating N-(1-alkylpyridin-4(1H)-ylidene)amide (PYA) ligands: Synthesis, characterization and evaluation of anticancer activity. J Inorg Biochem. 2021;224:111590.
- Reig M, Bosque R, Font-Bardía M, Calvis C, Messeguer R, Baldomà L, Badía J, Velasco D, López C. A study of the properties, reactivity, and anticancer activity of novel N-methylated-3-thiazolyl or 3-thienyl carbazoles and their Pd(II) and Pt(II) complexes. J Inorg Biochem. 2018;184:134–45.
- Oliveira CG, Romero-Canelón I, Coverdale JPC, Maia PIS, Clarkson GJ, Deflon VM, Sadler PJ. Novel tetranuclear PdII and PtII anticancer complexes derived from pyrene thiosemicarbazones. Dalton Trans. 2020;49(28):9595–9604.
- Kacar O, Cevatemre B, Hatipoglu I, Arda N, Ulukaya E, Yilmaz VT, Acilan C. The role of cell cycle progression for the apoptosis of cancer cells induced by palladium(II)-saccharinate complexes of terpyridine. Bioorg Med Chem. 2017;25(6):1770–77.
- Plumb JA. Cell sensitivity assays: the MTT assay. Methods Mol Med. 1999;28:25–30.
- Ndagi U, Mhlongo N, Soliman ME. Metal complexes in cancer therapy - an update from drug design perspective. Drug Des Devel Ther. 2017;11:599–616.
- Frezza M, Hindo S, Chen D, et al. Novel metals and metal complexes as platforms for cancer therapy. Curr Pharm Des. 2010;16(16):1813–25.
- Mjos KD, Orvig C. Metallodrugs in medicinal inorganic chemistry. Chem Rev. 2014;114(8):4540–63.
- Hernández W, Paz J, Carrasco F, et al. Synthesis and Characterization of New Palladium(II) Thiosemicarbazone Complexes and Their Cytotoxic Activity against Various Human Tumor Cell Lines. Bioinorg Chem Appl. 2013;2013:524701.
- Carreira M, Calvo-Sanjuán R, Sanaú M, Marzo I, Contel M. Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand as Potential Anticancer Agents. Organometallics. 2012;31(16):5772–81.
- Plutín AM, Mocelo R, Alvarez A, Ramos R, Castellano EE, Cominetti MR, Graminha AE, Ferreira AG, Batista AA. On the cytotoxic activity of Pd(II) complexes of N,N-disubstituted-N'-acyl thioureas. J Inorg Biochem. 2014;134:76–82.
- Jan R, Chaudhry GE. Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics. Adv Pharm Bull. 2019;9(2):205–18.
- Laubach V, Kaufmann R, Bernd A, Kippenberger S, Zöller N. Extrinsic or Intrinsic Apoptosis by Curcumin and Light: Still a Mystery. Int J Mol Sci. 2019;20(4):905.
- Kiraz Y, Adan A, Kartal Yandim M, Baran Y. Major apoptotic mechanisms and genes involved in apoptosis. Tumour Biol. 2016;37(7):8471–86.
- Goelz N, Eekels JJM, Pantic M, Kamber CT, Speer O, Franzoso FD, Schmugge M. Platelets express adaptor proteins of the extrinsic apoptosis pathway and can activate caspase-8. PLoS One. 2021;16(1):e0244848.
- Joksimović N, Janković N, Petronijević J, Baskić D, Popovic S, Todorović D, Zarić M, Klisurić O, Vraneš M, Tot A, Bugarčić Z. Synthesis, Anticancer Evaluation and Synergistic Effects with cisplatin of Novel Palladium Complexes: DNA, BSA Interactions and Molecular Docking Study. Med Chem. 2020;16(1):78–92.
- Espino J, Fernández-Delgado E, Estirado S, de la Cruz-Martinez F, Villa-Carballar S, Viñuelas-Zahínos E, Luna-Giles F, Pariente JA. Synthesis and structure of a new thiazoline-based palladium(II) complex that promotes cytotoxicity and apoptosis of human promyelocytic leukemia HL-60 cells. Sci Rep. 2020;10(1):16745.
- Keswani, T., Chowdhury, S., Mukherjee, S., & Bhattacharyya, A. Palladium(II) complex induces apoptosis through ROS-mediated mitochondrial pathway in human lung adenocarcinoma cell line (A549). Current Science. 2014;107(10);1711–19.
- Hadizadeh S, Najafzadeh N, Mazani M, Amani M, Mansouri-Torshizi H, Niapour A. Cytotoxic Effects of Newly Synthesized Palladium(II) Complexes of Diethyldithiocarbamate on Gastrointestinal Cancer Cell Lines. Biochem Res Int. 2014;2014:813457.